CeNC - Commission d'enquête nationale citoyenne - bio-statisticienne Christine Cotton témoigne

Key statements

• Cotton: 23 years as a biostatistician, founder of a CRO whose clients included AstraZeneca, Pfizer, Sanofi, Bayer, Aventis, and AB Science — covering oncology, CNS, autoimmune, pulmonology, ophthalmology, and more. ▶ 01:08
  Sources: Christine Cotton CV
• Cotton participated in close to 500 clinical trials over her career — including HCV, tuberculosis, kidney transplant, and diabetes work — establishing the credentialing baseline for her Pfizer critique. ▶ 02:35
  Sources: Christine Cotton CV
• Drug development normally takes ~15 years from discovery to authorization. The COVID vaccines benefited from accelerated development — each phase starting before the previous one finished, with incomplete results carried forward. ▶ 05:19
  Sources: Pfizer C4591001 Protocol
• Pregnant or lactating women were never included (standard for protected populations). Immunocompromised patients, those with comorbidities (diabetes, pulmonary disease), and patients with autoimmune or inflammatory conditions were also excluded — i.e., the most fragile populations. ▶ 06:31
  Sources: Pfizer C4591001 Protocol
• Interaction with other vaccines was not studied; transmission was not studied. Cotton emphasizes the bigger problem is not the (commonly cited) missing transmission data but the way symptomatic cases themselves were measured. ▶ 07:00
  Sources: Pfizer C4591001 Protocol
• Across every interim analysis (adults, 12-15 yrs, 5-11 yrs, infants), participants had a maximum of three months of follow-up — too short to support any "safe" claim beyond that horizon. ▶ 07:37
  Sources: Pfizer C4591001 interim clinical study reports (adults, 12-15, 5-11, infants)
• Per the court-released SAS tables (obtained via Aaron Siri's litigation in the US), there were fewer PCR tests in the vaccine arm than the placebo arm — meaning fewer confirmed COVID cases by design, not by protection. ▶ 09:43
  Sources: Pfizer C4591001 SAS datasets (court-released)
• GCP is a body of regulations, hundreds of documents, governing every task of every actor in a trial. A trial that violates GCP in its endpoint selection or analyses "is worth nothing." ▶ 10:49
  Sources: ICH-GCP guidelines
• Participants were allowed to take antipyretics — which suppress fever and other COVID-like symptoms. More vaccine-arm participants took them; their symptoms were suppressed, no PCR test was triggered, and the efficacy calculation is biased. ▶ 11:35
  Sources: Pfizer C4591001 Protocol; Pfizer C4591001 interim clinical study report (Dec 2020)
• Anti-nucleocapsid serology — measured but not used as the primary endpoint — gives a fuller picture. Recomputed efficacy on that table is about 55%, not 95%. ▶ 12:17
  Sources: Pfizer C4591001 SAS datasets (court-released)

Documents cited

• Pfizer C4591001 Protocol — NEJM supplementary materials
• Pfizer C4591001 interim clinical study reports (adults, 12-15 yrs, 5-11 yrs, infants) — FDA briefing documents and EMA EPAR archive
• Pfizer C4591001 SAS datasets (court-released) — PHMPT v. FDA litigation (Aaron Siri, ICAN)
• ICH-GCP guidelines — International Council for Harmonisation
• Christine Cotton CV — archive/documents/CV_Christine_Cotton_EN.md

• Locate the PCR-testing-rate comparison in the court-released SAS tables (vaccine arm vs. placebo arm) that supports Cotton's "fewer tests in vaccine arm" claim. Capture table name and the difference in tests-per-suspected-case.Cited at ~09:43 — supports the case-detection bias core argument.

  Sources she cites in the book

  • 150 OpenVAET (Substack) — "Pfizer/BioNTech C4591001 Trial Audit", independent re-analysis of the court-released C4591001 SAS datasets
  • Pfizer C4591001 trial data made publicly available via Aaron Siri (the court-released SAS datasets; the data Cotton recalculates from)
• Find and add Aaron Siri's / ICAN's litigation timeline (PHMPT v. FDA) — including the Pittman court order that produced the released datasets Cotton works from.Referenced at ~09:43 — important provenance for any reader following the data.

  Sources she cites in the book

  • Public Health and Medical Professionals for Transparency (PHMPT) — phmpt.org, the site posting the FDA's court-ordered released C4591001 clinical-trial documents ⧉ archived
  • 79 Complaint, PHMPT/de Garay v. FDA, filed 2022-10-11 (hosted on phmpt.org) — the litigation seeking the de Garay family's trial records ⧉ archived
  • 75 Siri & Glimstad LLP (Aaron Siri) — "Letter to Federal Health Agencies Regarding Maddie and Clinical Trials for Children", Oct 2021
• Find the CeNC (Commission d'enquête nationale citoyenne) full transcript or final report — to cross-reference Cotton's testimony date and embed the longer Q&A if available.The available video transcript ends abruptly around 13:23; the full hearing likely runs longer.